Home › Neurofibrosarcoma › Missouri › St. Louis
Neurofibrosarcoma clinical trials in St. Louis, MO
4 studies for Neurofibrosarcoma are looking for participants at sites in and around St. Louis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
SPEARHEAD-3 Pediatric Study
RecruitingPhase 1/2
- Washington University, St Louis
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
RecruitingPhase 1/2
- Washington University Medical Center, St Louis
A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
RecruitingPhase 2
- Washington University, St Louis
Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors
RecruitingObservational study
- Washington University School of Medicine, St Louis
Neurofibrosarcoma trials in other cities
- Washington, DC6 studies
- New York City, NY6 studies
- Boston, MA4 studies
- Chicago, IL3 studies
- Mountain View, CA3 studies
- Edison, NJ3 studies
- Queens, NY3 studies
- Cincinnati, OH3 studies
- Houston, TX3 studies
Other studies in St. Louis
- Non-Small Cell Lung Cancer73 studies
- Breast Cancer64 studies
- Metastatic Cancer54 studies
- Colorectal Cancer50 studies
- Prostate Cancer46 studies
- Cancer (all types)46 studies
- Lung Cancer39 studies
- Ovarian Cancer38 studies
- Pancreatic Cancer33 studies
- Endometrial Cancer29 studies
- Head and Neck Squamous Cell Carcinoma28 studies
- Heart Failure26 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.